CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
Do Young Kim, Jehyun Nam, Joo-seop Chung, Sang-Woo Kim, Ho-Jin Shin
Cancer Research and Treatment. 2022;54(1):301-313.   Published online 2021 April 27    DOI: https://doi.org/10.4143/crt.2020.1371

Excel Download

Role of Roflumilast Combined with ESHAP Chemotherapy in Relapsed/Refractory Patients with Diffuse Large B-Cell Lymphoma
Cancer Research and Treatment. 2022;54(1):301-313   Crossref logo
Link1 Link2 Link3

ESHAP Versus Rituximab-ESHAP in Frail Patients With Refractory Diffuse Large B-Cell Lymphoma
Clinical Lymphoma Myeloma and Leukemia. 2010;10(2):125-128   Crossref logo
Link1 Link2

Efficacy and Safety of Rituximab Combined with ESHAP Chemotherapy for the Treatment of Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
Clinical Lymphoma and Myeloma. 2007;7(6):406-412   Crossref logo
Link1 Link2

High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin’s lymphoma
Annals of Oncology. 1998;9:S1-S3   Crossref logo
Link1 Link2 Link3

Pretreatment prognostic factors and outcome in patients with relapsed or primary-refractory diffuse large B-cell lymphoma treated with second-line chemotherapy and autologous stem cell transplantation
Annals of Oncology. 2006;17:iv37-iv39   Crossref logo
Link1 Link2 Link3

ESHAP+fixed dose G-CSF as autologous peripheral blood stem cell mobilization regimen in patients with relapsed or refractory diffuse large cell and Hodgkin's lymphoma: a single institution result of 127 patients
Bone Marrow Transplantation. 2006;37(3):277-282   Crossref logo
Link1 Link2 Link3

R-ESHAP plus pegfilgrastim as an effective peripheral stem cell mobilization regimen for autologous stem-cell transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma
Transfusion and Apheresis Science. 2014;50(3):411-414   Crossref logo
Link1 Link2

How I manage patients with relapsed/refractory diffuse large B cell lymphoma
British Journal of Haematology. 2018;182(5):633-643   Crossref logo
Link1 Link2

TREATMENT OF RELAPSED, REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
Hematology, Transfusion and Cell Therapy. 2021;43:S4   Crossref logo
Link1 Link2

Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma
Annals of Hematology. 2013;93(3):403-409   Crossref logo
Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.